| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Reproductive Techniques, Assisted | 11 | 2021 | 81 | 1.770 |
Why?
|
| Polycystic Ovary Syndrome | 6 | 2023 | 67 | 1.210 |
Why?
|
| Infertility | 5 | 2019 | 76 | 1.080 |
Why?
|
| Fertilization in Vitro | 10 | 2022 | 155 | 1.040 |
Why?
|
| Infertility, Female | 3 | 2023 | 145 | 0.850 |
Why?
|
| Endometriosis | 3 | 2022 | 176 | 0.840 |
Why?
|
| Abortion, Spontaneous | 2 | 2022 | 81 | 0.790 |
Why?
|
| Anti-Mullerian Hormone | 3 | 2023 | 46 | 0.780 |
Why?
|
| Ovarian Reserve | 1 | 2023 | 15 | 0.770 |
Why?
|
| Progestins | 2 | 2019 | 39 | 0.630 |
Why?
|
| Endometrium | 6 | 2019 | 292 | 0.620 |
Why?
|
| Decidua | 6 | 2019 | 143 | 0.610 |
Why?
|
| Luteal Phase | 1 | 2019 | 8 | 0.600 |
Why?
|
| Pregnancy, Multiple | 5 | 2015 | 44 | 0.570 |
Why?
|
| Embryo Transfer | 6 | 2022 | 48 | 0.530 |
Why?
|
| Live Birth | 5 | 2022 | 75 | 0.520 |
Why?
|
| Societies, Medical | 6 | 2019 | 798 | 0.520 |
Why?
|
| Stromal Cells | 7 | 2019 | 316 | 0.520 |
Why?
|
| Oocytes | 5 | 2022 | 283 | 0.490 |
Why?
|
| Reproductive Medicine | 2 | 2019 | 20 | 0.450 |
Why?
|
| Fertility | 5 | 2022 | 260 | 0.450 |
Why?
|
| Quality Indicators, Health Care | 2 | 2019 | 240 | 0.410 |
Why?
|
| Pregnancy | 23 | 2022 | 7512 | 0.410 |
Why?
|
| Ovulation Induction | 3 | 2021 | 38 | 0.380 |
Why?
|
| Uterus | 3 | 2017 | 541 | 0.370 |
Why?
|
| Embryo Implantation | 5 | 2022 | 218 | 0.360 |
Why?
|
| Receptors, Progesterone | 5 | 2021 | 677 | 0.350 |
Why?
|
| Risk Management | 1 | 2012 | 67 | 0.350 |
Why?
|
| Laboratories | 1 | 2012 | 81 | 0.350 |
Why?
|
| Female | 43 | 2023 | 70963 | 0.340 |
Why?
|
| Pregnancy Rate | 5 | 2022 | 40 | 0.330 |
Why?
|
| Medical Errors | 1 | 2012 | 145 | 0.330 |
Why?
|
| Body Mass Index | 1 | 2015 | 1717 | 0.290 |
Why?
|
| Pregnancy Outcome | 2 | 2016 | 623 | 0.280 |
Why?
|
| Spermatozoa | 1 | 2010 | 254 | 0.280 |
Why?
|
| Ovary | 2 | 2021 | 345 | 0.280 |
Why?
|
| Immunoassay | 2 | 2021 | 126 | 0.270 |
Why?
|
| Biomarkers | 2 | 2016 | 3385 | 0.250 |
Why?
|
| Humans | 43 | 2023 | 131163 | 0.240 |
Why?
|
| Gene Expression Regulation | 6 | 2021 | 2323 | 0.240 |
Why?
|
| Practice Guidelines as Topic | 2 | 2009 | 1295 | 0.230 |
Why?
|
| Nuclear Receptor Coactivator 2 | 2 | 2018 | 147 | 0.220 |
Why?
|
| Transcriptome | 5 | 2021 | 1103 | 0.220 |
Why?
|
| Obesity | 2 | 2020 | 2426 | 0.220 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 371 | 0.210 |
Why?
|
| Follicle Stimulating Hormone | 3 | 2023 | 175 | 0.210 |
Why?
|
| Ovarian Diseases | 1 | 2004 | 23 | 0.210 |
Why?
|
| Quality of Health Care | 1 | 2007 | 413 | 0.200 |
Why?
|
| Retrospective Studies | 13 | 2022 | 17753 | 0.200 |
Why?
|
| Receptors, FSH | 1 | 2023 | 18 | 0.200 |
Why?
|
| Androgens | 2 | 2022 | 247 | 0.180 |
Why?
|
| Hyperandrogenism | 1 | 2022 | 19 | 0.180 |
Why?
|
| Early Growth Response Protein 1 | 2 | 2019 | 38 | 0.170 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2017 | 986 | 0.170 |
Why?
|
| Adult | 18 | 2021 | 31282 | 0.170 |
Why?
|
| Uterine Contraction | 1 | 2021 | 29 | 0.170 |
Why?
|
| Receptors, Oxytocin | 1 | 2021 | 20 | 0.170 |
Why?
|
| TRPC Cation Channels | 1 | 2021 | 19 | 0.170 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 2 | 2018 | 12 | 0.160 |
Why?
|
| Biological Products | 1 | 2022 | 145 | 0.160 |
Why?
|
| Multiple Birth Offspring | 3 | 2015 | 7 | 0.160 |
Why?
|
| Preimplantation Diagnosis | 1 | 2020 | 29 | 0.150 |
Why?
|
| Anniversaries and Special Events | 1 | 2019 | 10 | 0.150 |
Why?
|
| Placenta Previa | 1 | 2020 | 66 | 0.150 |
Why?
|
| Fetal Development | 1 | 2021 | 121 | 0.150 |
Why?
|
| Pregnancy, Twin | 1 | 2021 | 191 | 0.150 |
Why?
|
| Embryo, Mammalian | 2 | 2011 | 403 | 0.140 |
Why?
|
| Diet, Protein-Restricted | 1 | 2019 | 71 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 588 | 0.130 |
Why?
|
| Cryopreservation | 2 | 2012 | 79 | 0.130 |
Why?
|
| WNK Lysine-Deficient Protein Kinase 1 | 1 | 2017 | 14 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2017 | 11 | 0.130 |
Why?
|
| Vaccination | 1 | 2023 | 1060 | 0.130 |
Why?
|
| Pregnancy, Animal | 1 | 2017 | 66 | 0.130 |
Why?
|
| Placenta Accreta | 1 | 2020 | 182 | 0.130 |
Why?
|
| Cells, Cultured | 6 | 2019 | 2885 | 0.130 |
Why?
|
| Insulin Resistance | 1 | 2022 | 690 | 0.120 |
Why?
|
| Leiomyoma | 1 | 2017 | 71 | 0.120 |
Why?
|
| Mitochondria | 2 | 2020 | 785 | 0.120 |
Why?
|
| Cancer Care Facilities | 1 | 2016 | 32 | 0.120 |
Why?
|
| Folic Acid | 1 | 2019 | 269 | 0.120 |
Why?
|
| Cesarean Section | 1 | 2020 | 426 | 0.120 |
Why?
|
| Follicular Fluid | 1 | 2016 | 6 | 0.120 |
Why?
|
| Luteal Cells | 1 | 2016 | 8 | 0.120 |
Why?
|
| Uterine Neoplasms | 1 | 2017 | 100 | 0.120 |
Why?
|
| United States | 9 | 2019 | 12072 | 0.120 |
Why?
|
| Cell Proliferation | 4 | 2018 | 2465 | 0.120 |
Why?
|
| Amino Acids | 1 | 2019 | 566 | 0.120 |
Why?
|
| Dietary Supplements | 1 | 2019 | 448 | 0.120 |
Why?
|
| Fertility Preservation | 1 | 2016 | 62 | 0.120 |
Why?
|
| Prenatal Diagnosis | 1 | 2020 | 612 | 0.110 |
Why?
|
| Progesterone | 1 | 2017 | 439 | 0.110 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2016 | 111 | 0.110 |
Why?
|
| Single Embryo Transfer | 1 | 2015 | 3 | 0.110 |
Why?
|
| Choice Behavior | 1 | 2016 | 148 | 0.110 |
Why?
|
| Interferon Regulatory Factors | 1 | 2015 | 46 | 0.110 |
Why?
|
| Cleavage Stage, Ovum | 2 | 2011 | 4 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 597 | 0.100 |
Why?
|
| Phosphofructokinase-2 | 1 | 2013 | 22 | 0.100 |
Why?
|
| Transcription, Genetic | 2 | 2016 | 1363 | 0.100 |
Why?
|
| Genetic Testing | 1 | 2020 | 1106 | 0.100 |
Why?
|
| Quality Improvement | 1 | 2019 | 722 | 0.090 |
Why?
|
| Referral and Consultation | 1 | 2016 | 564 | 0.090 |
Why?
|
| Follicular Phase | 2 | 2019 | 10 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 371 | 0.090 |
Why?
|
| Databases as Topic | 1 | 2012 | 73 | 0.090 |
Why?
|
| Registries | 1 | 2019 | 1634 | 0.090 |
Why?
|
| Models, Statistical | 1 | 2014 | 483 | 0.090 |
Why?
|
| Blastomeres | 1 | 2011 | 6 | 0.090 |
Why?
|
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2010 | 2 | 0.080 |
Why?
|
| Editorial Policies | 1 | 2011 | 49 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2018 | 1590 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 224 | 0.080 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 712 | 0.080 |
Why?
|
| Comprehension | 1 | 2010 | 81 | 0.080 |
Why?
|
| Practice Management | 1 | 2009 | 6 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 2026 | 0.080 |
Why?
|
| Animals | 9 | 2022 | 33912 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 5196 | 0.070 |
Why?
|
| Informed Consent | 1 | 2012 | 351 | 0.070 |
Why?
|
| Birth Weight | 1 | 2010 | 347 | 0.070 |
Why?
|
| Cytokines | 3 | 2022 | 1339 | 0.070 |
Why?
|
| Prognosis | 2 | 2015 | 4886 | 0.070 |
Why?
|
| Age Factors | 1 | 2015 | 2825 | 0.070 |
Why?
|
| Inflammation | 1 | 2016 | 1489 | 0.070 |
Why?
|
| Periodicals as Topic | 1 | 2011 | 182 | 0.070 |
Why?
|
| Infant, Newborn | 4 | 2021 | 8635 | 0.070 |
Why?
|
| Mice | 6 | 2022 | 18301 | 0.070 |
Why?
|
| Annual Reports as Topic | 1 | 2007 | 2 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2020 | 789 | 0.070 |
Why?
|
| Communication | 1 | 2012 | 543 | 0.070 |
Why?
|
| Embryo Culture Techniques | 1 | 2007 | 19 | 0.070 |
Why?
|
| Oocyte Donation | 1 | 2007 | 5 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 378 | 0.060 |
Why?
|
| Time Factors | 2 | 2019 | 6196 | 0.060 |
Why?
|
| Gestational Age | 1 | 2010 | 1224 | 0.060 |
Why?
|
| Male | 7 | 2022 | 64957 | 0.060 |
Why?
|
| Program Development | 1 | 2007 | 179 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2007 | 146 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 3829 | 0.060 |
Why?
|
| Insurance Coverage | 1 | 2007 | 120 | 0.060 |
Why?
|
| Risk Factors | 3 | 2020 | 11074 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2011 | 1240 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2013 | 1928 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2022 | 4738 | 0.060 |
Why?
|
| Leuprolide | 1 | 2005 | 17 | 0.050 |
Why?
|
| Luteinizing Hormone | 1 | 2005 | 118 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2017 | 526 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2015 | 223 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2017 | 664 | 0.050 |
Why?
|
| Cell Movement | 2 | 2018 | 876 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2007 | 464 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 407 | 0.050 |
Why?
|
| Follicle Stimulating Hormone, Human | 1 | 2023 | 5 | 0.050 |
Why?
|
| Aromatase | 1 | 2023 | 23 | 0.050 |
Why?
|
| Embryo Research | 1 | 2003 | 8 | 0.050 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2023 | 82 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2019 | 12936 | 0.050 |
Why?
|
| Iridoid Glucosides | 1 | 2022 | 4 | 0.050 |
Why?
|
| Gonadotropins | 1 | 2002 | 31 | 0.050 |
Why?
|
| Clomiphene | 1 | 2002 | 15 | 0.050 |
Why?
|
| Granulosa Cells | 1 | 2023 | 143 | 0.050 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2002 | 69 | 0.050 |
Why?
|
| Delivery, Obstetric | 1 | 2005 | 257 | 0.050 |
Why?
|
| Organ Preservation | 1 | 2003 | 62 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2012 | 3711 | 0.050 |
Why?
|
| Estrogen Receptor beta | 1 | 2022 | 87 | 0.050 |
Why?
|
| Neoplasms | 1 | 2016 | 3016 | 0.040 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 1 | 2021 | 12 | 0.040 |
Why?
|
| Fertilization | 1 | 2021 | 44 | 0.040 |
Why?
|
| Sex Differentiation | 1 | 2021 | 18 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2017 | 2550 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2020 | 74 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2007 | 919 | 0.040 |
Why?
|
| Cell Shape | 2 | 2011 | 67 | 0.040 |
Why?
|
| Parturition | 1 | 2021 | 65 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2021 | 356 | 0.040 |
Why?
|
| Ovarian Follicle | 1 | 2021 | 127 | 0.040 |
Why?
|
| Estrogens | 1 | 2022 | 434 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 1801 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2020 | 265 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 1 | 2020 | 117 | 0.040 |
Why?
|
| Aneuploidy | 1 | 2020 | 138 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2020 | 233 | 0.040 |
Why?
|
| ROC Curve | 1 | 2021 | 613 | 0.040 |
Why?
|
| Cell Count | 2 | 2011 | 212 | 0.040 |
Why?
|
| Cumulus Cells | 1 | 2019 | 42 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 129 | 0.040 |
Why?
|
| Vitamin B Complex | 1 | 2019 | 36 | 0.040 |
Why?
|
| Young Adult | 3 | 2020 | 10103 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 321 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2019 | 299 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2019 | 263 | 0.030 |
Why?
|
| Role | 1 | 2017 | 27 | 0.030 |
Why?
|
| Data Collection | 2 | 2011 | 370 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2019 | 365 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 419 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2020 | 1211 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 204 | 0.030 |
Why?
|
| Kinetics | 1 | 2019 | 1088 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 1378 | 0.030 |
Why?
|
| Reproductive Health Services | 1 | 2016 | 24 | 0.030 |
Why?
|
| Genital Neoplasms, Female | 1 | 2016 | 43 | 0.030 |
Why?
|
| RNA Interference | 1 | 2018 | 491 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2017 | 171 | 0.030 |
Why?
|
| Chemokines | 1 | 2016 | 126 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2017 | 1013 | 0.030 |
Why?
|
| Fos-Related Antigen-2 | 1 | 2015 | 4 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2015 | 20 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2017 | 200 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 645 | 0.030 |
Why?
|
| Nucleotide Motifs | 1 | 2015 | 51 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 451 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2015 | 99 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2015 | 110 | 0.030 |
Why?
|
| Validation Studies as Topic | 1 | 2014 | 12 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 1481 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 1591 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 1207 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 1205 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 567 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2016 | 315 | 0.020 |
Why?
|
| Computational Biology | 1 | 2018 | 862 | 0.020 |
Why?
|
| Binding Sites | 1 | 2015 | 1133 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 293 | 0.020 |
Why?
|
| Retirement | 1 | 2011 | 18 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 2200 | 0.020 |
Why?
|
| Protein Binding | 1 | 2015 | 1652 | 0.020 |
Why?
|
| Base Sequence | 1 | 2015 | 2730 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 5063 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3464 | 0.020 |
Why?
|
| Logistic Models | 1 | 2015 | 1797 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 1490 | 0.020 |
Why?
|
| Software | 1 | 2015 | 733 | 0.020 |
Why?
|
| International Cooperation | 1 | 2010 | 165 | 0.020 |
Why?
|
| Reference Standards | 1 | 2010 | 231 | 0.020 |
Why?
|
| Europe | 1 | 2010 | 365 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 141 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 3359 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 2904 | 0.020 |
Why?
|
| Genome, Human | 1 | 2015 | 1321 | 0.020 |
Why?
|
| Adolescent | 2 | 2016 | 20987 | 0.020 |
Why?
|
| Maternal Age | 1 | 2007 | 136 | 0.020 |
Why?
|
| Research Design | 1 | 2010 | 716 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 6459 | 0.010 |
Why?
|
| Ambulatory Care Facilities | 1 | 2007 | 231 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2007 | 387 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 2602 | 0.010 |
Why?
|
| Hormone Antagonists | 1 | 2002 | 43 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 645 | 0.010 |
Why?
|
| Estradiol | 1 | 2005 | 460 | 0.010 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2002 | 38 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 1319 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 4686 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 28601 | 0.010 |
Why?
|